US 11,807,607 B1
Aminocarbazole compounds as antibacterial agents
Christophe Tratrat, Al-Ahsa (SA); and Michelyne Haroun, Al-Ahsa (SA)
Assigned to KING FAISAL UNIVERSITY, Al-Ahsa (SA)
Filed by KING FAISAL UNIVERSITY, Al-Ahsa (SA)
Filed on Mar. 29, 2023, as Appl. No. 18/128,085.
Application 18/128,085 is a continuation in part of application No. 18/119,742, filed on Mar. 9, 2023, granted, now 11,780,809.
This patent is subject to a terminal disclaimer.
Int. Cl. C07D 209/88 (2006.01); A61P 31/06 (2006.01); C07D 403/04 (2006.01); C07D 401/12 (2006.01)
CPC C07D 209/88 (2013.01) [A61P 31/06 (2018.01); C07D 401/12 (2013.01); C07D 403/04 (2013.01)] 19 Claims
 
1. A compound having the formula I:

OG Complex Work Unit Chemistry
or a pharmaceutically acceptable salt, ester, stereoisomer, or solvate thereof, wherein:
R1 is hydrogen, C1-C6 alkyl, or C3-C6 cycloalkyl;
R2 is hydrogen or a halogen; and
R3 is an aryl, heteroaryl, arylamine, or heteroarylamine, each of which may be optionally substituted with from one to three substituents, and wherein each of the from one to three substituents is independently selected from the group consisting of hydrogen, —COOH, —CH2COOH, a trihaloalkoxy group, a trihaloalkyl group, and an alkoxy group.